Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-10T11:53:30.676Z Has data issue: false hasContentIssue false
  • English
  • Français

Evaluating a clinical practice intervention to promote delivery of salbutamol by metered-dose inhalers with holding chambers in a pediatric emergency department

Published online by Cambridge University Press:  04 March 2015

Barbara J. Hill-Taylor ,
Katrina F. Hurley ,
Ingrid Sketris ,
Colleen O'Connell ,
Douglas Sinclair  and
Andrew Wing
Barbara J. Hill-Taylor*
Affiliation:
IMPART, College of Pharmacy, Dalhousie University, Halifax, NS
Katrina F. Hurley
Affiliation:
Emergency Department, IWK Health Centre, Halifax, NS
Ingrid Sketris
Affiliation:
IMPART, College of Pharmacy, Dalhousie University, Halifax, NS
Colleen O'Connell
Affiliation:
IWK Health Centre, Halifax, NS
Douglas Sinclair
Affiliation:
St. Michael's Hospital, Toronto, ON
Andrew Wing
Affiliation:
Dalhousie Medical School, Dalhousie University, Halifax, NS
*
IMPART, College of Pharmacy, 1459 Oxford Street, Halifax, NS B3H 4R2; Barbara.Hill-Taylor@dal.ca

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

The primary objective of this study was to quantify the impact of a clinical practice intervention to promote the delivery of salbutamol by metered-dose inhaler (MDI) in a pediatric emergency department (PED). A secondary objective was to retrospectively document the components of the intervention.

Methods:

PED inventory data for salbutamol inhalation solution (nebules), MDIs, and holding chambers were obtained from the pharmacy department. Patient data were obtained fromthe hospital's decision support unit. Interrupted time series analysis was used to evaluate trends in salbutamol inventory data, patient triage acuity, and hospital admissions from January 1, 2003, to May 31, 2010. Interviews and administrative documents were used to identify components of the intervention, which began in 2006.

Results:

There was a 1,215% increase in the proportion of salbutamol delivered as MDIs compared to total inhaled salbutamol (MDI plus nebulization solution) following the intervention (95% CI 1,032% to 1,396%, p < 0.001). Increases in salbutamol MDI use were associated with the implementation of an institution-specific asthma care map. A relative decrease of 32% in the hospital admission rate (absolute –7.25%: 95% CI –8.31 to –6.19, p < 0.001) was associated with the change in salbutamol MDI use and the use of the asthma care map.

Conclusions:

A multifaceted intervention, designed and implemented by local PED clinical leaders, resulted in a pronounced change in salbutamol inhalation practice, with an associated decrease in admission rates. This intervention demonstrated many of the criteria for successful health system change. Findings from this research may be contextualized to inform change elsewhere.

Keywords

asthma therapyclinical interventionhealth service researchpediatric emergency departmentsalbutamol inhalation
Type
Original Research • Recherche originale
Information
Canadian Journal of Emergency Medicine , Volume 15 , Issue 2 , March 2012 , pp. 101 - 108
Copyright
Copyright © Canadian Association of Emergency Physicians 2013

References

REFERENCES

1.Amirav, I, Newhouse, MT. Metered-dose inhaler accessory devices in acute asthma - efficacy and comparison with nebulizers: A literature review. Arch Pediatr Adolesc Med 1997;151:876–82, doi:10.1001/archpedi.1997.02170460014003.Google Scholar
2.Benito-Fernández, J, González-Balenciaga, M, Capapé-Zache, S, et al. Salbutamol via metered-dose inhaler with spacer versus nebulization for acute treatment of pediatric asthma in the emergency department. Pediatr Emerg Care 2004;20:656–9, doi:10.1097/01.pec.0000142948.73512.81.Google Scholar
3.Cates, CJ, Crilly, JA, Rowe, BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006;(2)CD000052, DOI:10.1002/14651858.CD000052.pub2.Google Scholar
4.Chou, KJ, Cunningham, SJ, Crain, EF. Metered-dose inhalers with spacers vs nebulizers for pediatric asthma. Arch Pediatr Adolesc Med 1995;149:201–5, doi:10.1001/archpedi.1995.02170140083015.Google Scholar
5.Cunningham, SJ, Crain, EF. Reduction of morbidity in asthmatic children given a spacer device. Chest 1994;106:753–7, doi:10.1378/chest.106.3.753.Google Scholar
6.Dewar, AL, Stewart, A, Cogswell, JJ, et al. A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital. Arch Dis Child 1999;80:421–3, doi:10.1136/adc.80.5.421.Google Scholar
7.Leversha, AM, Campanella, SG, Aickin, RP, et al. Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma. J Pediatr 2000;136:497–502, doi:10.1016/S0022-3476(00)90013-1.Google Scholar
8.Rubilar, L, Castro-Rodriguez, JA, Girardi, G. Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age. Pediatr Pulmonol 2000;29:264–9, doi:10.1002/(SICI)1099-0496(200004)29:4,<264::AID-PPUL5>3.0.CO;2-S.3.0.CO;2-S>CrossRefGoogle Scholar
9.Schuh, S, Johnson, DW, Stephens, D, et al. Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr 1999;135:22–7, doi:10.1016/S0022-3476(99)70322-7.Google Scholar
10.Dolovich, MB, Ahrens, RC, Anderson, P, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127:335–371, doi:10.1378/chest.127.1.335.CrossRefGoogle ScholarPubMed
11.Scott, SD, Osmond, MH, O’Leary, KA, et al. Barriers and supports to implementation of MDI/spacer use in nine Canadian pediatric emergency departments: A qualitative study. Implement Sci 2009;4:65, doi:10.1186/1748-5908-4-65.Google Scholar
12.Mason, N, Roberts, N, Yard, N, et al. Nebulisers or spacers for the administration of bronchodilators to those with asthma attending emergency departments? Respir Med 2008;102:993–8, doi:10.1016/j.rmed.2008.02.009.Google Scholar
13.Babl, FE, Sheriff, N, Borland, M, et al. Paediatric acute asthma management in Australia and New Zealand: Practice patterns in the context of clinical practice guidelines. Arch Dis Child 2008;93:307–12.Google Scholar
14.Clark, NM, Houle, C, Partridge, MR, et al. The puzzle of continued use of nebulized therapy by those with asthma. Chron Respir Dis 2010;7:3–7, doi:10.1177/1479972309357496.Google Scholar
15.Osmond, MH, Gazarian, M, Henry, RL, et al. Barriers to metered-dose inhaler/spacer use in Canadian pediatric emergency departments: A national survey. Acad Emerg Med 2007;14:1106–13.Google Scholar
16.Rallo, M, Bertone, A, Bignamini, E. Guala, A. Lack of use of MDI device in acute asthma: An Italian survey. Pediatr Pulmonol 2009;44:1244–5, doi:10.1002/ppul.21118.Google Scholar
17.Global Initiative for Asthma. Global strategy for the diagnosis and management of asthma in children 5 years and younger. 2009. Available at: http://www.ginasthma.org (accessed October 25, 2010).Google Scholar
18.Becker, A, Bérubé, D, Chad, Z, et al. Canadian Network For Asthma Care; Canadian Thoracic Society. Canadian Pediatric Asthma Consensus guidelines, 2003 (updated to December 2004): Introduction. CMAJ 2005;173(6Suppl):S12-14.Google Scholar
19.National Asthma EducationPrevention Program. Expert panel report 3 (EPR-3): Guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007;120(5 Suppl):S94-138.Google Scholar
20.Hurley, KF, Sargeant, J, Duffy, J, et al. Perceptual reasons for resistance to change in the emergency department use of holding chambers for children with asthma. Ann Emerg Med 2008;51:70–7, doi:10.1016/j.annemergmed.2007.04.008.Google Scholar
21. IWK Health Centre. About Us. 2009. Available at: http://www.iwk.nshealth.ca. (accessed October 25, 2010).Google Scholar
22.Canadian Institutes of Health Information. Database background and general data limitations documentation. National Ambulatory Care Reporting System. 2008–2009. Executive Summary. Ottawa: CIHI; 2009. Available at: http://www.cihi.ca/CIHI-ext-portal/pdf/internet/nacrs_exec_summ_2008_2009_EN (accessed November 6, 2012).Google Scholar
23.World Health Organization. International statistical classification of diseases and related health problems: tenth revision. 2nd ed. 2004. Available at: http://www.who.int/classifications/icd/en/(accessed October 25, 2010).Google Scholar
24.Hendeles, L, Hatton, RC, Coons, TJ, et al. Automatic replacement of albuterol nebulizer therapy by metered-dose inhaler and valved holding chamber. Am J Health Syst Pharm 2005;62:1053–61.Google Scholar
25.Gazarian, M, Henry, RL, Wales, SR, et al. Evaluating the effectiveness of evidence-based guidelines for the use of spacer devices in children with acute asthma. Med J Aust 2001;174:394–7.Google Scholar
26.Powell, CV, Maskell, GR, Marks, MK, et al. Successful implementation of spacer treatment guideline for acute asthma. Arch Dis Child 2001;84:142–6, doi:10.1136/adc.84.2.142.Google Scholar
27.Gildenguys, J, Lee, M, Isbister, GK. Does implementation of a paediatric asthma clinical practice guideline worksheet change clinical practice. Int J Emerg Med 2009;2:33–39, doi:10.1007/s12245-008-0063-x.Google Scholar
28.Rogers, EM. Diffusion of innovations. 4th ed. New York: The Free Press; 1995.Google Scholar
29.Ganz, DA, Yano, EM, Saliba, D, Shekelle, PG. Design of a continuous quality improvement program to prevent falls among community-dwelling older adults in an integrated healthcare system. BMC Health Serv Res 2009;9:206, doi:10.1186/1472-6963-9-206.Google Scholar
30.England, E. How interrupted time series analysis can evaluate guideline implementation. Pharm J 2005;275:344–347.Google Scholar
31.Wagner, AK, Soumerai, SB, Zhang, F, Ross-Degnan, D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299–309, doi:10.1046/j.1365-2710.2002.00430.x.Google Scholar
32.Lummis, H, Sketris, I, Veldhuyzen van Zanten, S. Systematic review of the use of patients‘ own medications in acute care institutions. J Clin Pharm Ther 2006;31:541–63, doi:10.1111/j.1365-2710.2006.00773.x.Google Scholar
33.Sketris, IS, Langille Ingram, EM, Lummis, HL. Strategic opportunities for effective optimal prescribing and medication management. Can J Clin Pharmacol 2009;16:e103-25.Google Scholar
34.Rowe, BH, Spooner, C, Ducharme, F, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database of Systematic Reviews 2001;(1): CD002178. Doi:10.1002/14651858.CD002178.Google Scholar
35.Bhogal, SK, McGillvray, D, Bourbeau, J, et al. Early administration of systemic corticosteroids reduces hospital admission rates for children with moderate and severe asthma exacerbation. Ann Emerg Med 2012;60:84–91. e3. Epub 2012 Mar 10.Doi:10.1016/j.annemergmed.2011.12.027.Google Scholar
36.Bowton, D, Goldsmith, W, Haponik, E. Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large acute-care hospital. Chest 1992;101:305–8, doi:10.1378/chest.101.2.305.CrossRefGoogle Scholar
37.Khoo, SM, Tan, LK, Said, N, et al. Metered-dose inhaler with spacer instead of nebulizer during the outbreak of severe acute respiratory syndrome in Singapore. Respir Care 2009;54:855–60, doi:10.4187/002013209793800411.Google Scholar
38.Rodriguez-Martinez, CE, Sossa, M, Lozano, JM. Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children. Cochrane Database Syst Rev 2008;(2):CD005536.Google Scholar